​

Orchestra BioMed Ownership | Who Owns Orchestra BioMed?

OverviewForecastRevenueFinancialsChart

Orchestra BioMed Ownership Summary

Orchestra BioMed is owned by 59.90% institutional investors, 26.21% insiders, and 13.89% retail investors. Rtw investments, lp is the largest institutional shareholder, holding 21.63% of OBIO shares.

OBIO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockOrchestra BioMed59.90%26.21%13.89%
SectorHealthcare Stocks 35.49%11.75%52.76%
IndustryBiotech Stocks 34.83%11.71%53.46%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Rtw investments, lp8.31M21.63%$35.30M
Perceptive advisors5.04M13.12%$21.41M
Vanguard group1.60M4.18%$6.66M
Alyeska investment group1.00M2.60%$4.25M
Propel bio management896.70K2.34%$3.83M
Millennium management702.54K1.83%$2.99M
Blackrock funding, inc. /de635.71K1.66%$2.70M
Geode capital management485.49K1.26%$2.06M
Knoll capital management455.13K1.19%$421.16K
Affinity asset advisors402.55K1.05%$1.71M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Propel bio management896.70K2.41%$3.83M
Lasry marc60.87K1.00%$150.96K
Knott david m jr253.65K0.64%$1.08M
Amh equity166.00K0.51%$411.68K
Perceptive advisors5.04M0.42%$21.41M
Rtw investments, lp8.31M0.35%$35.30M
Knoll capital management455.13K0.23%$421.16K
Cannon global investment management22.61K0.19%$96.08K
Dafna capital management126.84K0.12%$539.07K
Holos integrated wealth51.59K0.11%$219.79K

Top Buyers

HolderShares% AssetsChange
Propel bio management896.70K2.41%896.70K
Millennium management702.54K0.00%459.07K
Vanguard fiduciary trust235.21K0.00%235.21K
Simplify asset management219.39K0.01%219.39K
Amh equity166.00K0.51%166.00K

Top Sellers

HolderShares% AssetsChange
Pathstone---1.01M
Price t rowe associates inc /md/---364.64K
Affinity asset advisors402.55K0.09%-170.25K
Jane street group55.68K--118.08K
Exoduspoint capital management, lp---95.64K

New Positions

HolderShares% AssetsChangeValue
Propel bio management896.70K2.41%896.70K$3.83M
Vanguard fiduciary trust235.21K0.00%235.21K$999.66K
Simplify asset management219.39K0.01%219.39K$932.39K
Amh equity166.00K0.51%166.00K$411.68K
Brevan howard capital management lp36.77K0.00%36.77K$156.27K

Sold Out

HolderChange
Eversource wealth advisors-1.00
True wealth design-6.00
Gamma investing-101.00
Sierra ocean-119.00
Russell investments group-193.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202664-3.03%22,997,8025.97%591.87%4216.67%13-18.75%
Dec 31, 202511-78.85%1,738,363-92.42%40.13%7-72.00%--100.00%
Sep 30, 202510-82.76%1,953,498-89.23%50.23%4-88.57%3-81.25%
Jun 30, 2025585.45%18,134,637-4.51%471.91%3552.17%16-11.11%
Mar 31, 2025548.00%18,940,1491.07%492.00%22-31.25%18157.14%

Recent Insider Transactions

DateNameRoleActivityValue
May 18, 2026Aryeh Jason-Buy$2.49K
May 15, 2026Aryeh Jason-Buy$34.99K
May 15, 2026Hochman David P See RemarksBuy$18.85K
May 14, 2026Fain Eric S-Buy$82.60K
Apr 27, 2026RTW INVESTMENTS, LP-Sell$132.16

Insider Transactions Trends

DateBuySell
2026 Q2-1
2026 Q11-
2025 Q41-
2025 Q39-
2025 Q221

OBIO Ownership FAQ

Who Owns Orchestra BioMed?

Orchestra BioMed shareholders are primarily institutional investors at 59.90%, followed by 26.21% insiders and 13.89% retail investors. The average institutional ownership in Orchestra BioMed's industry, Biotech Stocks , is 34.83%, which Orchestra BioMed exceeds.

Who owns the most shares of Orchestra BioMed?

Orchestra BioMed’s largest shareholders are Rtw investments, lp (8.31M shares, 21.63%), Perceptive advisors (5.04M shares, 13.12%), and Vanguard group (1.6M shares, 4.18%). Together, they hold 38.94% of Orchestra BioMed’s total shares outstanding.

Does Blackrock own Orchestra BioMed?

BlackRock is not among the top 10 institutional shareholders of Orchestra BioMed.

Who is Orchestra BioMed’s biggest shareholder by percentage of total assets invested?

Propel bio management is Orchestra BioMed’s biggest shareholder by percentage of total assets invested, with 2.41% of its assets in 896.7K Orchestra BioMed shares, valued at 3.83M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools